GPAA1
Basic information
Region (hg38): 8:144082337-144093149
Links
Phenotypes
GenCC
Source:
- glycosylphosphatidylinositol biosynthesis defect 15 (Strong), mode of inheritance: AR
- glycosylphosphatidylinositol biosynthesis defect 15 (Strong), mode of inheritance: AR
- glycosylphosphatidylinositol biosynthesis defect 15 (Supportive), mode of inheritance: AR
- glycosylphosphatidylinositol biosynthesis defect 15 (Strong), mode of inheritance: AR
- glycosylphosphatidylinositol biosynthesis defect 15 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Glycosylphosphatidylinositol biosynthesis defect 15 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 29100095 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (15 variants)
- Glycosylphosphatidylinositol biosynthesis defect 15 (5 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPAA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 145 | 150 | ||||
missense | 208 | 222 | ||||
nonsense | 9 | |||||
start loss | 1 | |||||
frameshift | 12 | 13 | ||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 13 | 16 | ||||
splice region | 12 | 14 | 3 | 29 | ||
non coding | 72 | 79 | ||||
Total | 18 | 21 | 220 | 222 | 12 |
Highest pathogenic variant AF is 0.0000329
Variants in GPAA1
This is a list of pathogenic ClinVar variants found in the GPAA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-144082731-A-C | Glycosylphosphatidylinositol biosynthesis defect 15 | Uncertain significance (Mar 22, 2022) | ||
8-144082736-C-G | Likely benign (Oct 03, 2022) | |||
8-144082737-C-G | Uncertain significance (Sep 29, 2022) | |||
8-144082747-A-G | Inborn genetic diseases | Uncertain significance (Sep 22, 2022) | ||
8-144082749-C-T | Uncertain significance (Jul 28, 2022) | |||
8-144082750-C-T | Uncertain significance (Jul 10, 2023) | |||
8-144082756-G-A | Uncertain significance (Jul 03, 2022) | |||
8-144082759-G-A | Glycosylphosphatidylinositol biosynthesis defect 15 • Inborn genetic diseases | Uncertain significance (Sep 06, 2022) | ||
8-144082763-C-A | Likely benign (Nov 12, 2023) | |||
8-144082765-C-T | Uncertain significance (Aug 16, 2022) | |||
8-144082766-G-A | Likely benign (Dec 22, 2022) | |||
8-144082770-GC-G | Glycosylphosphatidylinositol biosynthesis defect 15 | Pathogenic/Likely pathogenic (May 28, 2024) | ||
8-144082775-C-T | Likely benign (Jan 13, 2022) | |||
8-144082779-G-T | Inborn genetic diseases | Uncertain significance (Jul 06, 2022) | ||
8-144082781-G-A | Likely benign (Aug 30, 2023) | |||
8-144082781-G-T | Likely benign (Dec 13, 2023) | |||
8-144082782-C-G | Uncertain significance (Feb 27, 2022) | |||
8-144082788-C-T | Uncertain significance (Dec 14, 2022) | |||
8-144082792-A-G | Uncertain significance (Jun 27, 2023) | |||
8-144082793-C-T | Likely benign (Jun 27, 2023) | |||
8-144082801-TGTG-T | Uncertain significance (Dec 14, 2021) | |||
8-144082805-G-A | Likely pathogenic (May 13, 2023) | |||
8-144082808-A-G | Uncertain significance (Jun 03, 2022) | |||
8-144082813-A-G | Likely benign (Jul 19, 2022) | |||
8-144082819-C-G | Likely benign (Oct 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPAA1 | protein_coding | protein_coding | ENST00000355091 | 12 | 3627 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.50e-9 | 0.851 | 124713 | 0 | 108 | 124821 | 0.000433 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.868 | 324 | 371 | 0.873 | 0.0000220 | 3880 |
Missense in Polyphen | 97 | 105.51 | 0.91936 | 1138 | ||
Synonymous | -0.431 | 180 | 173 | 1.04 | 0.0000105 | 1423 |
Loss of Function | 1.65 | 17 | 26.1 | 0.652 | 0.00000120 | 279 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00100 | 0.000986 |
Ashkenazi Jewish | 0.000497 | 0.000497 |
East Asian | 0.00106 | 0.00106 |
Finnish | 0.0000467 | 0.0000464 |
European (Non-Finnish) | 0.000418 | 0.000415 |
Middle Eastern | 0.00106 | 0.00106 |
South Asian | 0.000328 | 0.000327 |
Other | 0.000339 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Essential for GPI-anchoring of precursor proteins but not for GPI synthesis. Acts before or during formation of the carbonyl intermediate. {ECO:0000269|PubMed:29100095, ECO:0000269|PubMed:9468317}.;
- Pathway
- Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human);Attachment of GPI anchor to uPAR;Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- loftool
- 0.215
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.49
Haploinsufficiency Scores
- pHI
- 0.0944
- hipred
- N
- hipred_score
- 0.335
- ghis
- 0.492
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.819
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpaa1
- Phenotype
Gene ontology
- Biological process
- protein retention in ER lumen;attachment of GPI anchor to protein;protein-containing complex assembly
- Cellular component
- endoplasmic reticulum membrane;membrane;GPI-anchor transamidase complex
- Molecular function
- GPI-anchor transamidase activity;protein binding;tubulin binding;GPI anchor binding